What Really Happens After 2 Years on a GLP-1? NEW RESEARCH

What happens when you stay on a GLP-1 for two years? Do you really need the full dose forever? And could the next generation of obesity medications be less about losing more weight and more about making treatment easier to live with? In this week’s episode of The Downsized News, Christopher and Laraine Durham break down the latest GLP-1 news, research and real-world data shaping obesity treatment. Novo Nordisk has launched a new Phase 3 trial studying whether some patients may be able to maintain results on lower doses of the Wegovy pill. New Epic Research data from more than 25,000 patients shows what actually happened during the second year of treatment with semaglutide and tirzepatide. The episode also looks at new maintenance data involving Foundayo, the growing competition between oral Wegovy and orforglipron, and an experimental daily pill called ENV-308 that is being developed as a possible way to help maintain weight loss after GLP-1 treatment. Christopher and Laraine also cover early semaglutide research in women with PCOS, Novo Nordisk’s mysterious new obesity drug, the push toward obesity medications with fewer gastrointestinal side effects, and why GLP-1 prices are now part of the national conversation about prescription drug inflation. Plus, rapid GLP-1 weight loss is creating an unexpected problem for the fashion industry, with bridal shops, retailers and consumers adapting to bodies that may change several clothing sizes in a matter of months. The Downsized News follows the latest developments in GLP-1 medications, Wegovy, Zepbound, tirzepatide, semaglutide, obesity treatment, weight loss maintenance, GLP-1 side effects, oral GLP-1 drugs, Foundayo, orforglipron, PCOS, amylin medications and next-generation weight loss drugs. Christopher and Laraine are GLP-1 patients who have lost more than 150 pounds together. They are not doctors. They read the studies, follow the clinical trials and earnings calls, interview patients and experts, and break down what the latest developments may mean for people living with obesity and using GLP-1 medications. +++++++++++++++++++++++++++++++++++++++ Start your weight loss journey today! We use Mochi Health: https://app.joinmochi.com/eligibility... Use Laraine’s code for $40 off: QIYGO8. Get your Hume BodyPod today and use our exclusive Downsized code for up to 20% total savings! 👉 Use our Code: THEDOWNSIZED Link to purchase: https://humehealth.com//discount/THED... SHOP OUR AMAZON STORE: https://a.co/d/0gGe1MYq BOOK THE DOWNSIZED AT SEA CRUISE 2027: https://thedownsized.org/downsized-at... GET YOUR DOWNSIZED LIVE! ON TOUR TICKETS: https://thedownsized.org/meet-ups/ DOWNSIZED WEBSITE: https://thedownsized.org/ JOIN CLUB DOWNSIZED: https://www.youtube.com/@thedownsized... FOR SPONSORSHIPS, BRAND DEALS & COLLABS: https://thedownsized.org/contact/ +++++++++++++++++++++++++++++++++++++++ 00:00 What Really Happens After 2 Years on a GLP-1? DOWNSIZED NEWS 01:36 Downsized News 01:38 Do You Really Need the Full Wegovy Dose? 06:06 What Happens After 2 Years on a GLP-1? 10:02 Novo’s Mystery New Weight Loss Drug 12:50 Can Semaglutide Help PCOS Beyond Weight Loss? 15:48 Could an “Exercise Pill” Prevent GLP-1 Weight Regain? 19:23 Are GLP-1s Actually Bringing Inflation Down? 22:46 How GLP-1 Weight Loss Is Changing the Clothing Industry 26:19 The Next GLP-1 Breakthrough May Be Fewer Side Effects 28:43 DOWNSIZED LIVE ON TOUR!